Cysts Are NOT Common in Steroid Sulfatase Deficiency-Associated Glomerulopathy
Steroid sulfatase (STS) deficiency, which causes X-linked ichthyosis, is not typically associated with renal cysts but rather with glomerular podocytopathy presenting as nephrotic syndrome, most commonly minimal change disease or focal segmental glomerulosclerosis (FSGS). The provided evidence contains no documentation of cystic kidney disease as a feature of STS deficiency-related glomerulopathy 1.
Key Clinical Features of STS Deficiency Glomerulopathy
The renal manifestations of STS deficiency are characterized by:
- Steroid-resistant nephrotic syndrome as the primary presentation
- Minimal change disease on renal biopsy (most commonly reported) 1
- FSGS in some cases 2
- Absence of cystic changes in the kidneys
Pathophysiology
The mechanism underlying proteinuria in STS deficiency involves:
- Cholesterol sulfate accumulation due to enzyme deficiency
- Disruption of adherens junctions between glomerular epithelial cells at the slit diaphragm
- Podocytopathy leading to proteinuria without cyst formation 1
This represents a genetic cause of podocyte dysfunction, not a cystic kidney disease.
Clinical Presentation Pattern
When STS deficiency affects the kidneys, expect:
- Ichthyotic skin present since birth (X-linked recessive ichthyosis)
- Male predominance (X-linked inheritance)
- Nephrotic-range proteinuria with hypoalbuminemia
- Steroid resistance in most cases
- Response to calcineurin inhibitors (cyclosporine) or rituximab 1, 2
Important Distinction
While one case report describes congenital anomalies of the kidney and urinary tract (CAKUT) with STS gene deletion 3, this involved a contiguous gene deletion syndrome at Xp22.31 affecting multiple genes beyond STS alone. The kidney abnormalities in that case were structural malformations, not simple cysts, and represented a broader genetic syndrome rather than isolated STS deficiency.
Clinical Pitfall to Avoid
Do not confuse STS deficiency glomerulopathy with polycystic kidney diseases. The guidelines provided discuss ADPKD and other cystic nephropathies [4-5], but these are entirely separate entities from STS deficiency. If you encounter a patient with ichthyosis and renal disease, look for proteinuria and nephrotic syndrome, not cysts on imaging.
Management Implications
For suspected STS deficiency with glomerulopathy:
- Obtain renal biopsy to document podocytopathy (minimal change disease or FSGS)
- Genetic testing for STS gene deletion
- Initiate calcineurin inhibitor therapy (cyclosporine) rather than steroids alone 1
- Consider rituximab for steroid-resistant cases 2
- Do NOT pursue workup for cystic kidney diseases unless other clinical features suggest a different diagnosis